Lipid Raft-Targeted Therapy in Multiple Myeloma

Oncogene - United Kingdom
doi 10.1038/onc.2010.131
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

MET/HGF Pathway in Multiple Myeloma: From Diagnosis to Targeted Therapy?

Expert Review of Molecular Diagnostics
Forensic MedicineGeneticsPathologyMolecular MedicineMolecular Biology
2015English

BiTE Therapy Active in Multiple Myeloma

Cancer Discovery
Oncology
2019English

CD38-Targeted Immunochemotherapy in Refractory Multiple Myeloma: A New Horizon

Clinical Cancer Research
Cancer ResearchOncology
2015English

Exploiting Lipid Raft Transport With Membrane Targeted Nanoparticles: A Strategy for Cytosolic Drug Delivery

Biomaterials
Mechanics of MaterialsBiophysicsBiomaterialsBioengineeringCompositesNanoscienceNanotechnologyCeramics
2008English

Lipid Raft Alterations in Aged-Associated Neuropathologies

Current Alzheimer Research
Neurology
2016English

Chimeric Antigen Receptor T-Cell Therapy for Multiple Myeloma

International Journal of Hematology
Hematology
2020English

GPRC5D CAR T-Cell Therapy Has Antitumor Activity in Multiple Myeloma

Cancer Discovery
Oncology
2019English

Frontline Therapy in Multiple Myeloma: Fast Start for a Long Game

The Lancet Haematology
Hematology
2019English

Prognostic Significance of Upfront Radiation Therapy in Patients With Multiple Myeloma

American Journal of Hematology
Hematology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy